REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx®, a leader in interventional pulmonology, today announced publication of an expert panel recommendation in Respiration which concluded that only the ...

The Zephyr Endobronchial Valve has been given market approval by the Food and Drug Administration. The treatment is for those with severe emphysema, which is a type of chronic obstructive pulmonary ...

The US Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx Corp) to treat breathing difficulty associated with severe emphysema. "Treatment options are limited for ...

In a breakthrough for patients suffering from severe COPD or Emphysema, Metro Health – University of Michigan Health has become one of the first Michigan health systems to offer a new minimally ...

The approval was based on results from a multicenter study (LIBERATE) of 190 patients with severe emphysema. The Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx ...

Pulmonx ® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr ® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the ...

Connecticut COPD patients now have access to a new life-changing treatment in Hartford. The first patient at Saint Francis Hospital to get the procedure since it newly became available says it has ...

The FDA today approved the Zephyr endobronchial valve for treating breathing difficulty associated with severe emphysema, according to a press release. “Treatment options are limited for people with ...

EL PASO, Texas (KFOX14/CBS4) — The Hospitals of Providence Memorial Campus performed El Paso’s first successful breakthrough lung procedureto treat patients suffering from COPD and emphysema. The ...

For patients with severe emphysema, the new technology allows for treatment of the chronic disease without major invasive surgery. For the past 15 years, Michael McPheeters, 71, has had trouble with ...